Latest Oncotype DX Stories
Expanded Reimbursement in Canada and Inclusion in Leading German Physician Guidelines Increase Genomic Health's Impact in Key International Markets REDWOOD CITY, Calif., April 22,
Data Presented at 9th European Breast Cancer (EBCC-9) Symposium Highlights Comprehensive Body of Clinical Evidence for Oncotype DX REDWOOD CITY, Calif., March 19, 2014 /PRNewswire/ -- Genomic
Genomic Health Successfully Launched a Viral Educational Concept for Reaching People Touched by Breast Cancer Titled “Pass It On, Until Every Woman Knows” Indianapolis,
15% Increase in Full-Year Test Volume; 21% Increase in 4th Quarter Test Volume REDWOOD CITY, Calif., Feb. 4, 2014 /PRNewswire/ -- Genomic Health, Inc.
New data show real-life impact of Oncotype DX on treatment decisions, underscore clinical validity and utility of the test REDWOOD CITY, Calif., Jan.
REDWOOD CITY, Calif., Jan. 28, 2014 /PRNewswire/ -- Genomic Health, Inc.
- Agreement to Distribute Oncotype DX(R) in Australia and New Zealand MELBOURNE, Australia, Jan.
REDWOOD CITY, Calif., Jan. 6, 2014 /PRNewswire/ -- Genomic Health, Inc.
A new test has the potential to help physicians identify patients with the most lethal forms of triple-negative breast cancer, a disease which requires aggressive and innovative treatment.
- One of a pair of round metal cymbals attached to the fingers and struck together for rhythm and percussion in belly dancing.